Genomic Health
The Oncotype DX Breast Recurrence Score® test is a personalized test that shows how likely breast cancer is to return—and if patients may benefit from chemotherapy.
Basic Information
- Category: Laboratory Testing
- Founded: 2000
- Headquarters: Redwood City, CA
- Website: oncotype.com
Documented Facts
- Parent company: Exact Sciences Corporation (No linked source recorded for this statement.)
Evidence and Sources
- Genomic Health — Official Site (official)
- Genomic Health on instagram (social)
- Genomic Health on facebook (social)
- Genomic Health on linkedin (social)
Citation Guidance
Explore Laboratory Testing profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Genomic Health.
- Canonical profile: https://brandsource.ai/brands/genomic-health
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/genomic-health/json-ld
- Citation profile API: https://brandsource.ai/api/brands/genomic-health/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (85/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-31T09:48:36.304Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
The Oncotype DX Breast Recurrence Score® test is a personalized test that shows how likely breast cancer is to return—and if patients may benefit from chemotherapy.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.